Putative Biomarkers and Targets of Estrogen Receptor Negative Human Breast Cancer
Author Information
Author(s): Sahab Ziad J., Man Yan-Gao, Byers Stephen W., Sang Qing-Xiang A.
Primary Institution: Georgetown University Medical Center
Hypothesis
The study investigates potential biomarkers and therapeutic targets for estrogen receptor negative breast cancer.
Conclusion
The research highlights the importance of targeting estrogen receptor negative breast cancer and its associated cancer stem cells to improve treatment outcomes.
Supporting Evidence
- Estrogen receptor negative breast cancer cells express fewer proteins than their estrogen receptor positive counterparts.
- Cancer stem cells in ER negative tumors retain the ability to self-renew, making them a target for therapy.
- Targeting ER negative breast cancer and its stem cells may improve treatment outcomes.
Takeaway
This study looks at special markers in breast cancer that doesn't respond to estrogen, which could help doctors find better treatments.
Methodology
The study reviews existing literature and data on biomarkers related to estrogen receptor negative breast cancer.
Limitations
The review is limited by the heterogeneity of breast cancer and the complexity of protein biomarkers.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website